SCHEMBL22778799

SCHEMBL22778799

CCCCCCCC(CC)N1C[C@H](N)C2(CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22778852 0.92 DNM1 (0.31) —
SCHEMBL22778851 0.91 — —
SCHEMBL22778773 0.76 CHRM2 (0.30) —
SCHEMBL22778595 0.76 OPRM1 (0.33) —
SCHEMBL22778770 0.74 — —
SCHEMBL22778607 0.72 — —
SCHEMBL23865782 0.71 — —
SCHEMBL11644117 0.70 FDPS (0.39) —
SCHEMBL11643350 0.70 FDPS (0.39) —
SCHEMBL9419611 0.70 FDPS (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10865216-B2 Tricyclic Gyrase inhibitors MERCK SHARP & DOHME CORP. (US) 2020-12-15 — — US disclosed
Send feedback